SkinBioTherapeutics

(SBTX)
Sector: Pharmaceuticals & Biotechnology
15.60p
-0.40p -2.49
Last updated: 11:39:00

Director dealings

Trade date Director Volume / Price Trade value Trade type
06/04/2023 Manprit Singh Randhawa 66,778 @ 16.00p £10,684.48 Sell
06/04/2023 Manprit Singh Randhawa 66,778 @ 16.03p £10,704.51 Buy
06/04/2023 Stuart Ashman 123,878 @ 16.25p £20,130.18 Sell
06/04/2023 Stuart Ashman 122,517 @ 16.25p £19,909.01 Buy
06/04/2023 Stuart Ashman 122,517 @ 16.25p £19,909.01 Buy
06/03/2023 Manprit Singh Randhawa 86,387 @ 22.75p £19,653.04 Buy
06/03/2023 Manprit Singh Randhawa 89,472 @ 22.75p £20,354.88 Sell
06/03/2023 Stuart Ashman 86,387 @ 22.75p £19,653.04 Buy
06/03/2023 Stuart Ashman 89,472 @ 22.75p £20,354.88 Sell

Director shareholdings

Name Holding Percent
Martin Braddock Hunt 466,667 0.00%
Manprit Singh Randhawa 455,060 0.00%
Stuart Ashman 455,060 0.00%
Catherine Denise Prescott 118,612 0.00%

Major shareholders

Institution name Holding Percent
OptiBiotix Health 24,940,639 11.03%
Tyndall Investment Management 13,165,553 7.60%
David Campbell Brierwood 9,347,929 4.10%
Unicorn Asset Management Limited 7,894,736 3.94%